Breast gene link to lung cancer death

A gene that increases susceptibility to breast cancer may also predict worse outcomes in lung cancer patients, a European study has shown.

High levels of the BRCA1 breast cancer gene have been shown to double the risk of mortality over three years following surgery for non-small cell lung cancer (NSCLC).

Outcomes in NSCLC patients could be improved by offering adjuvant chemotherapy to those with high levels of the gene, the researchers suggested.

They analysed tumour samples taken from 126 Polish patients during surgery for NSCLC. They then measured levels of five genes believed to play a role in progression of NSCLC, including BRCA1.

Of the five genes, only BRCA1 was found to be predictive of survival. Patients with high levels of BRCA1 expression had a 98 per cent increased risk of dying within three years of surgery, compared with patients with low levels of BRCA1.

In the 36 patients whose tumours had high levels of BRCA1, event-free survival was 22 months on average.

Examination of NSCLC tumour samples from a separate group of 58 patients confirmed high BRCA1 expression more than doubled the risk of death.

Speaking at the European Cancer Conference in Barcelona last week, lead researcher Dr Rafael Rosell, from the Catalan Institute of Oncology in Barcelona, said: 'Our research shows that patients whose tumours had high BRCA1 expression had worse survival and should be candidates for adjuvant chemotherapy.'

He added that earlier studies had shown that different levels of BRCA1 expression affect response to different types of chemotherapy.

'BRCA1 could be a landmark predictor of chemosensitivity in NSCLC. We believe patients with the highest expression levels should receive antimicrotubule, non-platinum-based chemotherapy,' he said.

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

PCNs forced to opt out of phase 2 of COVID-19 vaccination programme over workload pressure

PCNs forced to opt out of phase 2 of COVID-19 vaccination programme over workload pressure

Some PCNs have opted out of phase 2 of the COVID-19 vaccination programme, with others...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

CVT risk from COVID-19 infection 'significantly higher' than from vaccines, study suggests

CVT risk from COVID-19 infection 'significantly higher' than from vaccines, study suggests

The risk of cerebral venous thrombosis (CVT) following COVID-19 infection is eight...

‘Warm and kind’ retired Derbyshire GP dies from COVID-19

‘Warm and kind’ retired Derbyshire GP dies from COVID-19

Retired Derbyshire GP Dr Om Prakash Chawla, who was known for his warmth and kindness,...

GPs can learn from pandemic to strengthen relationship with patients, says RCGP chair

GPs can learn from pandemic to strengthen relationship with patients, says RCGP chair

General practice can build on changes to care during the COVID-19 pandemic to strengthen...

Surrey GP practice targeted by aggressive anti-vaccination poster

Surrey GP practice targeted by aggressive anti-vaccination poster

Staff at a GP surgery in Surrey have been left completely demoralised after they...